There is new hope for millions of Britons whose high blood pressure does not respond to medication. Researchers at St Barts Hospital are testing a new technique being described as the “most exciting” development in the field.
Michel Azizi, France, Mel Lobo, United Kingdom and Felix Mahfoud, Germany, talk to Atul Pathak, France, about the current state of the renal denervation field and its future.
Michel Azizi explains and comments on the major results of the DENER-HTN study he just had published in The Lancet. This landmark trial in the field shows that renal denervation, done in a very controlled way with very strict methodologies, is able to bring added value to a very specific population in terms of blood pressure reduction.
Mel Lobo discusses his paper published in The Lancet, showing beneficial effects of a new approach and opening the part for personalisation of therapy according to the phenotype of the patient.
Lastly, Felix Mahfoud discusses the clinical consensus paper from the European Heart Journal meant as a guidance for the field and for future investigations.